The ERK1/2 signalling cascade appears to be involved in diverse pathogenic processes, not only in oncogenesis but also in the context of Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS) (for reviews, see9, 10). The gene discussed is MAPK3; the disease is early-onset autosomal dominant Alzheimer disease.